Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kirson Eilon D.
Chief Science Officer at NovoCure. Filing since 9 Jun 2017.
CIK 0001654356
Company
Date
Role
Action
Shares
Amount
Of holding
NVCR
NovoCure Ltd
17 Jan 2019
Chief Science Officer
Sold, plan not stated
68,813
$3.11M
38.7%
NVCR
NovoCure Ltd
16 Jan 2019
Chief Science Officer
Sold, plan not stated
100,000
$4.51M
47.8%
NVCR
NovoCure Ltd
4 Jun 2018
Chief Science Officer
Sold, plan not stated
346,161
$10.00M
91.3%
NVCR
NovoCure Ltd
18 Apr 2018
Chief Science Officer
Sold, plan not stated
147,825
$3.55M
78.9%
NVCR
NovoCure Ltd
11 Jan 2018
Chief Science Officer
Sold, plan not stated
25,320
$557.13K
88.8%
NVCR
NovoCure Ltd
6 Nov 2017
Chief Science Officer
Sold, plan not stated
9,100
$200.20K
24.2%
NVCR
NovoCure Ltd
3 Nov 2017
Chief Science Officer
Sold, plan not stated
3,100
$68.20K
7.6%
NVCR
NovoCure Ltd
2 Nov 2017
Chief Science Officer
Sold, plan not stated
300
$6.60K
0.7%
NVCR
NovoCure Ltd
1 Nov 2017
Chief Science Officer
Sold, plan not stated
22,119
$486.81K
35.0%
NVCR
NovoCure Ltd
31 Oct 2017
Chief Science Officer
Sold, plan not stated
150
$3.30K
0.2%
NVCR
NovoCure Ltd
21 Jun 2017
Chief Science Officer
Sold, plan not stated
66,361
$1.11M
23.0%
NVCR
NovoCure Ltd
19 Jun 2017
Chief Science Officer
Sold, plan not stated
15,000
$225.89K
4.9%
NVCR
NovoCure Ltd
13 Jun 2017
Chief Science Officer
Sold, plan not stated
9,044
$135.77K
2.9%
NVCR
NovoCure Ltd
12 Jun 2017
Chief Science Officer
Sold, plan not stated
5,956
$89.83K
1.9%
NVCR
NovoCure Ltd
9 Jun 2017
Chief Science Officer
Sold, plan not stated
15,000
$225.23K
4.5%
15 decisions on file.
